Firma Mindpeak, Autor bei Presse-Blog

Mindpeak Opens Boston Office to Accelerate Precision Pathology in the US

19. August 202519. August 2025 Firma MindpeakAllgemeinAI-Powered, Biotech, Boston, cancer therapies, CDx development, clinical diagnostics, drug development, high-quality insights, innovation hubs, laboratory capabilities, mindpeak, pathology, Precision Medicine, predictive biomarkers, translational research

Mindpeak, a global leader in AI-powered pathology solutions, today announced the launch of Mindpeak Inc., its dedicated US entity. Strategically positioned near key pharmaceutical, biotech, and diagnostic laboratory hubs in Boston, Massachusetts, the new presence brings Mindpeak’s advanced tissue AI Mehr

AstraZeneca und Mindpeak verkünden Zusammenarbeit und internationale Studie zum Einsatz KI-gestützter Brustkrebsdiagnostik

21. März 2025 Firma MindpeakAllgemeinastrazeneca, Diagnosegenauigkeit, diagnosetechnologie, digitale Pathologie, Effizienzsteigerung, Frauengesundheit, Internationale Zusammenarbeit, Krebsdiagnostik, künstliche intelligenz, medizinische Innovation, mindpeak, Onkologie, partnerschaft, pathologen, Pathologieoptimierung

Mindpeak, ein führender Anbieter von KI-gestützten Lösungen für die digitale Pathologie, gibt eine neue Partnerschaft mit dem weltweit agierenden biopharmazeutischen Unternehmen AstraZeneca bekannt. Gemeinsam führen die beiden Unternehmen eine internationale Studie zur Bewertung der digitalen Pathologie und des Einsatzes von Mehr

Mindpeak sets standards with PD-L1 Cell Atlas

10. Oktober 202314. Oktober 2023 Firma MindpeakMedizintechnikatlas, biomarker, cancer, cell, cells, discovery, drugs, ecp, immunotherapy, medical, mindpeak, pathology, research, treatment, with

Europe’s leading provider of AI software for pathology, Mindpeak (Hamburg), has announced groundbreaking work with leading expert pathologists to improve AI-assisted cancer diagnosis. The collaboration on a "PD-L1 Cell Atlas" marks a significant step in medical research and helps to Mehr

Mindpeak announces CE-mark for new product: Breast HER2 RoI

20. Juli 202220. Juli 2022 Firma MindpeakMedizintechnikbreast, cancer, clinical, company, deruxtecan, enhertu, her2, ihc, market, mindpeak, new, pathology, therapy, trastuzumab, with

Mindpeak announces the CE-mark for another new product: Mindpeak Breast HER2 RoI (Region of Interest) supports pathologists in the scoring of digital images of breast cancer tissue, which underwent immunohistochemical (IHC) staining of the human epidermal growth factor receptor 2 Mehr

Mindpeak announces scanner agnostic CE-marked PD-L1 AI solution to support Lung Cancer Diagnosis

9. Juni 20229. Juni 2022 Firma MindpeakMedizintechnikcancer, cell, cells, clinical, ivd, learning, market, medical, mindpeak, new, nsclc, pathology, research, tps, with

Mindpeak, European leader in Artificial Intelligence in Pathology, today announced the launch of a new CE marked deep learning algorithm for Lung Cancer diagnosis. “Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI“ is a plug-and-play AI solution to detect and quantify PD-L1 Mehr

Mindpeak announces first CE-marked fully automated software to support breast cancer tissue diagnosis

24. Mai 20222. Juni 2022 Firma MindpeakMedizintechnikbreast, cancer, cells, clinical, company, faber, learning, mindpeak, new, pathology, series, software, treatment, tumor, with

Mindpeak, European leader in Artificial Intelligence in Pathology, today announced the launch of a new CE marked deep learning algorithm for breast cancer diagnosis. "Mindpeak Breast Ki-67 HS" is the first AI software worldwide which directly proposes automatically recognized and Mehr

Mindpeak kündigt erste CE-markierte vollautomatisierte Software zur Unterstützung der Befundung von Brustkrebsgewebe an

24. Mai 2022 Firma MindpeakMedizintechnikbreast, brustkrebs, faber, frauen, hotspots, klinische, learning, lösung, mindpeak, pathologen, pathologie, patienten, software, Tumorzellen, unternehmen

Mindpeak, europäischer Marktführer im Bereich der Künstlichen Intelligenz in der Pathologie, gab heute die Markteinführung eines neuen CE gekennzeichneten Deep-Learning-Algorithmus für die Brustkrebsbefundung bekannt: “Mindpeak Breast Ki-67 HS” ist weltweit die erste KI-Software, die dem Pathologen beim erstmaligen Öffnen der Mehr

Mindpeak und Crosscope bieten gemeinsame Lösung für die digitale Pathologie insbesondere in Schwellenländern wie Indien an

28. Februar 2022 Firma MindpeakMedizintechnikbiomarker, breastihc, brustkrebs, brustkrebszellen, crosscope, faber, frauen, her2, microscope, milliarden, mindpeak, mindpeaks, mountain, pathologielabore, software

Mindpeak aus Hamburg und die in den USA ansässige Crosscope Inc. (Mountain View, CA) bieten ab sofort gemeinsam eine umfassende Lösung für die digitale Pathologie an, die somit nicht nur in den USA und Europa, sondern insbesondere auch in Schwellenländern Mehr

Mindpeak and Crosscope team up to provide a digital pathology platform with integrated Artificial Intelligence for primary diagnosis particular in India

28. Februar 2022 Firma MindpeakMedizintechnikbreast, breastihc, cancer, cells, clinical, crosscope, her2, mindpeak, mindpeaks, mountain, pathology, patients, power, tumorous, with

Germany based Mindpeak GmbH (Hamburg) and USA based Crosscope Inc. (Mountain View, CA) are now teaming up to deliver a comprehensive solution for digital pathology to be used not only in USA and Europe but also particular in emerging countries Mehr

Paige and Mindpeak Announce Partnership to Expand Access to Industry-Leading AI Software for Breast Cancer

15. Februar 202211. Februar 2022 Firma MindpeakMedizintechnikbreast, breastihc, cancer, cell, cells, clinical, her2, lis, mindpeak, mindpeaks, pathology, patients, storage, tumorous, with

Paige, the global leader in AI-based diagnostic software in pathology, and Mindpeak, the European leader for AI-based software for image analysis in pathology, today announced a distribution partnership, which will enable pathologists to use Mindpeak’s BreastIHC* within the Paige Platform. Mehr

Autor: Firma Mindpeak